Thanks to Susan Fletcher for permission to publish her Letter to the Editor to the Coast Reporter.
Measles can be alleviated by Vitamin A – unfortunately, autism cannot. New research reveals the very real possibility that MMR vaccine is a major contributor to the autism epidemic.
The first person to study the brains of autistic people was Dr Carlos Pardo of John Hopkins University. In studies published in 2005 and 2009 he and his team concluded that the brains of autistic people are permanently inflamed.
Dr Paul Patterson of the California Institute of Technology was the first to demonstrate that immune activation at critical times in brain development can lead to autism. It had been widely accepted that viral or bacterial activation of the immune system of a pregnant woman could affect the neurodevelopment of her foetus but Dr Patterson’s 2006 paper titled ‘Pregnancy, immunity, schizophrenia, and autism’ showed similar effects via maternal vaccinations.
Many vaccines contain aluminum hydroxide to hyper-stimulate an immune response. In 2009, UBC’s Dr Chris Shaw was the first person to test the effects of aluminum hydroxide by injecting it into the muscles of mice at intervals timed according to the childhood vaccine schedule for aluminum-containing vaccines (Hepatitis B, DTaP or Tdap, Hib, PCV and HPV). He and his team were surprised at how soon behavioral and cognitive deficits began. Upon examining the mice’s brains and spinal cords, they found massive damage to motor neurons.
In 2017, Dr Christopher Exley of England’s Keele University found high levels of aluminum in the brains of autistic people and confirmed the discovery by French scientists that immune cells called macrophages escort injected aluminum into the brain. Research suggests that, because it produces a strong immune response, the live virus MMR vaccine facilitates macrophage aluminum transport to the brains of babies and toddlers when aluminum from previous vaccines has been stored in their tissues.
Vargas DL, Nascimbene C, Krishnan C, Zimmerman AW, Pardo CA. Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann Neurol 2005; 57(1):67-81.
Patterson PH. Pregnancy, immunity, schizophrenia, and autism. Engineering & Science 2006; 3:10-21.
Li X, Chauhan A, Sheikh AM, et al. Elevated immune response in the brain of autistic patients. J Neuroimmunol 2009; 207(1-2):111-6.
Khan Z, Combadière C, Authier FJ […] Gherardi RK, Cadusseau J. Slow CCL2-dependent translocation of biopersistent particles from muscle to brain. BMC Med 2013; 11:99.
Gherardi RK, Eidi H, Crépeaux G, Authier FJ, Cadusseau J. Biopersistence and brain translocation of aluminum adjuvants of vaccines. Front Neurol 2015;6:4.
Miller NZ. Aluminum in childhood vaccines is unsafe. Journal of American Physicians and Surgeons 2016; 21(4):109-17.
Crépeaux G, Eidi H, David MO […] Cadusseau J, Gherardi RK. Non-linear dose-response of aluminium hydroxide adjuvant particles: selective low dose neurotoxicity. Toxicology 2017;375:48-57.
Mold M, Umar D, King A, Exley C. Aluminium in brain tissue in autism. J Trace Elem Med Biol 2018;46:76-82.
Nelson K. Aluminum in vaccines: what everyone needs to know. Wise Traditions 2018;19(1):94-98.